Wet Age-related Macular Degeneration (wAMD)
6 clinical trials · Condition
◉ Watch Wet Age-related Macular Degeneration (wAMD)
| Record | Firm | Date |
|---|---|---|
| High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain (HEIRLOOM) (NCT07129239) | Clinique de Retine de l'est | 2025-08-20 |
| To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD) (NCT06888492) | Guangzhou Jiayin Biotech Ltd | 2025-03-28 |
| Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD (NCT06839339) | Beijing Anlong Biopharmaceutical Co., Ltd. | 2025-02-18 |
| Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD (NCT06718816) | Beijing Anlong Biopharmaceutical Co., Ltd. | 2024-12-09 |
| Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD (NCT06707753) | Beijing Anlong Biopharmaceutical Co., Ltd. | 2023-09-11 |
| Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word（STONE） (NCT03054818) | Chengdu Kanghong Biotech Co., Ltd. | 2016-10-01 |
Track Wet Age-related Macular Degeneration (wAMD) automatically
Every clearance here is in the API, with alerts when new ones post.